web
You’re offline. This is a read only version of the page.
close

RESPIRATORY RESEARCH

ID 42: CAPP study - Effect of Cost on Adherence in Asthma

About the study

We are seeking people with stable asthma for an exciting new study to hear about how asthma treatment can be adjusted for each patient’s needs.
Asthma preventer treatment is decided for each person individually, as different people need different amounts of medication to control symptoms and prevent attacks. Finding the right dose for you means you won’t be taking more treatment than you need.

What's involved

The study involves two chats with a pharmacist experienced in asthma management about your asthma medications and what gets in the way of having your preventer scripts filled. We will ask you to complete some online questionnaires before and during the study and also ask you about your experience with the pharmacist.

Visits required

0

Eligibility criteria

  • Over 18 years
  • Have been told by a doctor or nurse that they have asthma, and have had asthma treatment or asthma symptoms in the last 12 months
  • Have been prescribed a preventer inhaler within the last 12 months
  • Are willing to provide written consent

Chief investigator: Professor Helen Reddel

Ethics approvals:

This study has been approved by the HREC of the University of Sydney [2019/325] which is a registered human ethics committee in accordance with the National Statement on Ethical Conduct of Human Research (2007) incorporating all updates.

Find out more

Contact: Gloria Foxley

Call: Text 'asthma study' to 0410818012 and Gloria will contact you

Email: gloria.foxley@sydney.edu.au